Clinical trial
Escitalopram in Treating Depression in Patients With Advanced Lung or…
NCT00387348 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00387348 |
|---|---|
| Title | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer |
| Official title | Symptom Management Trial in Cancer Survivors |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Depression, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Fatigue, Gallbladder Cancer, Gastric Cancer, Liver Cancer, Lung Cancer, Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | escitalopram oxalate, Placebo |
| Enrollment | 24 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Oct 13, 2006 |
| Last update posted | Dec 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: